International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral leishmaniasis (VL) in the immunodeficient host. There are currently no guidelines on how to treat such patients and efficacy of miltefosine monotherapy seems limited in this indication. We present 2 cases of patients with VL and AIDS for which LAmb had to be interrupted (one because of toxicity, one because of treatment failure) and who were treated effectively with pentamidine followed by miltefosine
<p>Initial treatment outcomes of visceral leishmaniasis and HIV co-infected patients treated with a ...
We describe here a case of disseminated cutaneous leish-maniasis due to Leishmania major in a severe...
We report a retrospective and descriptive study of four immunocompromised patients (three with HIV-1...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
North-west Ethiopia faces the highest burden world-wide of visceral leishmaniasis (VL) and HIV co-in...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
Visceral leishmaniasis (VL) has become an important opportunistic infection in persons with HIV-infe...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
<p>Initial treatment outcomes of visceral leishmaniasis and HIV co-infected patients treated with a ...
We describe here a case of disseminated cutaneous leish-maniasis due to Leishmania major in a severe...
We report a retrospective and descriptive study of four immunocompromised patients (three with HIV-1...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
International audienceLiposomal amphotericin B (LAmb) may fail to heal Leishmania infantum visceral ...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
North-west Ethiopia faces the highest burden world-wide of visceral leishmaniasis (VL) and HIV co-in...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
Visceral leishmaniasis (VL) has become an important opportunistic infection in persons with HIV-infe...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limite...
<p>Initial treatment outcomes of visceral leishmaniasis and HIV co-infected patients treated with a ...
We describe here a case of disseminated cutaneous leish-maniasis due to Leishmania major in a severe...
We report a retrospective and descriptive study of four immunocompromised patients (three with HIV-1...